References
- Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond)). 2017;17(1):65–70.
- Cañas CA, Tobón GJ, Arango LG, et al. Developing of granulomatous thyroiditis during etanercept therapy. Clin Rheumatol. 2009;28(S1):17–S19.
- Vassilopoulos D, Sialevris K, Malahtari S, et al. Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment. J Clin Rheumatol. 2010;16(2):88–89.
- Yasuji I. Subacute thyroiditis in a patient with juvenile idiopathic arthritis undergoing etanercept treatment: a case report and review of the literature. Mod Rheumatol. 2013;23(2):397–400.
- Pascart T, Ducoulombier V, Roquette D, et al. Autoimmune thyroid disorders during anti-TNF alpha therapy: Coincidence, paradoxical event or marker of immunogenicity? Joint Bone Spine. 2014;81(4):369–370.
- Chiriac A, Foia L, Chiriac AE, et al. A case of subacute thyroiditis in a patient on adalimumab for treatment of refractory palmo-plantar psoriasis. Muller J Med Sci Res. 2014;5:70–73.
- Kawashima J, Naoe H, Sasaki Y, et al. A rare case showing subacute thyroiditis-like symptoms with amyloid goiter after anti-tumor necrosis factor therapy. Endocrinol Diabetes Metab Case Rep. 2015;2015:140117.
- André R, Opris A, Costantino F, et al. Cytomegalovirus subacute thyroiditis in a patient treated by infliximab for psoriatic arthritis. Joint Bone Spine. 2016;83(1):109–110.
- Senlis M, Ottaviani S, Gardette A, et al. Subacute thyroiditis in psoriatic arthritis treated by adalimumab. Joint Bone Spine. 2017;84(6):745–746.
- Wei YA, Chuang WC, Hong CH. Subacute thyroiditis in a patient with psoriasis treated with a tumor necrosis factor-α inhibitor. Int J Dermatol. 2018;57(7):869–871.
- Slatosky J, Shipton B, Wahba H. Thyroiditis: differential diagnosis and management. Am Fam Physician. 2000;61(4):1047–1052.
- Ohsako N, Tamai H, Sudo T, et al. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab. 1995;80(12):3653–3656.
- Mitsushige N. Drug-induced thyroid diseases. Nihon Naika Gakkai Zasshi. 2010;99:776–785.
- Mazziotti G, Sorvillo F, Piscopo M, et al. Innate and acquired immune system in patients developing interferonα-related autoimmune thyroiditis: A prospective study. J Clin Endocrinol Metabol. 2005;90(7):4138–4144.
- Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocrine Rev. 2001;22:240–254.
- Ajjan RA, Watson PF, Weetman AP. Cytokines and thyroid function. Adv Neuroimmunol. 1996;6(4):359–386.
- Aust G, Heuer M, Laue S, et al. Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol. 1996;105(1):148–154.
- Li H, Zhang X, Gao L, et al. TNF-alpha is upregulated in subacute thyroiditis and stimulates expression of miR-155-5p in thyroid follicle cells. Discov Med. 2018;26(142):67–77.
- Abellán PG, Pérez-Lázaro A, Aguilera VS, et al. Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C. Endocrinol Nutr. 2009;56:136–139.
- Shen L, Bui C, Mansberg R, et al. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C. Clin Nucl Med. 2005;30(8):546–547.
- Falaschi P, Martocchia A, D’urso R, et al. Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C. J Endocrinol Invest. 1997;20(1):24–28.
- Munera-Campos M, Ballesca F, Carrascosa JM. Paradoxical reactions to biologic therapy in psoriasis:a review of the literature. Actas Dermosifiliogr. 2018;109(9):791–800.
- Seneschal J, Milpied B, Vergier B, et al. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol. 2009;161(5):1081–1088.